Explore
Validate
Learn
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [7]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 16027-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#16027-1-AP, RRID:AB_2183214
- Product name
- S100A1 antibody
- Antibody type
- Polyclonal
- Description
- S100A1 antibody (Cat. #16027-1-AP) is a rabbit polyclonal antibody that shows reactivity with human and has been validated for the following applications: IF, IHC, WB,ELISA.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Pleiotropic effects of nitric oxide sustained-release system for peripheral nerve repair.
S100A1 expression is increased in spinal cord injury and promotes inflammation, oxidative stress and apoptosis of PC12 cells induced by LPS via ERK signaling.
An injectable and adaptable hydrogen sulfide delivery system for modulating neuroregenerative microenvironment.
Oriented nanofibrous P(MMD-co-LA)/Deferoxamine nerve scaffold facilitates peripheral nerve regeneration by regulating macrophage phenotype and revascularization.
Reynoutrin Improves Ischemic Heart Failure in Rats Via Targeting S100A1.
Anti-Apoptotic Effect of IGF1 on Schwann Exposed to Hyperglycemia is Mediated by Neuritin, a Novel Neurotrophic Factor.
S100A1 in human heart failure: lack of recovery following left ventricular assist device support.
Huo Y, Cheng Y, Dong X, Cheng Q, Liang X, Duan P, Yu Y, Yan L, Qiu T, Pan Z, Dai H
Acta biomaterialia 2024 Jul 1;182:28-41
Acta biomaterialia 2024 Jul 1;182:28-41
S100A1 expression is increased in spinal cord injury and promotes inflammation, oxidative stress and apoptosis of PC12 cells induced by LPS via ERK signaling.
Bai Y, Guo N, Xu Z, Chen Y, Zhang W, Chen Q, Bi Z
Molecular medicine reports 2023 Feb;27(2)
Molecular medicine reports 2023 Feb;27(2)
An injectable and adaptable hydrogen sulfide delivery system for modulating neuroregenerative microenvironment.
Dong X, Zhang H, Duan P, Liu K, Yu Y, Wei W, Wang W, Liu Y, Cheng Q, Liang X, Huo Y, Yan L, Yu A, Dai H
Science advances 2023 Dec 22;9(51):eadi1078
Science advances 2023 Dec 22;9(51):eadi1078
Oriented nanofibrous P(MMD-co-LA)/Deferoxamine nerve scaffold facilitates peripheral nerve regeneration by regulating macrophage phenotype and revascularization.
Dong X, Wu P, Yan L, Liu K, Wei W, Cheng Q, Liang X, Chen Y, Dai H
Biomaterials 2022 Jan;280:121288
Biomaterials 2022 Jan;280:121288
Reynoutrin Improves Ischemic Heart Failure in Rats Via Targeting S100A1.
Yang W, Tu H, Tang K, Huang H, Ou S, Wu J
Frontiers in pharmacology 2021;12:703962
Frontiers in pharmacology 2021;12:703962
Anti-Apoptotic Effect of IGF1 on Schwann Exposed to Hyperglycemia is Mediated by Neuritin, a Novel Neurotrophic Factor.
Yan L, Xie M, Lu H, Zhang H, Shi M, Zhang Y, Xi C, Li J, Yang T
Molecular neurobiology 2018 Jan;55(1):495-505
Molecular neurobiology 2018 Jan;55(1):495-505
S100A1 in human heart failure: lack of recovery following left ventricular assist device support.
Bennett MK, Sweet WE, Baicker-McKee S, Looney E, Karohl K, Mountis M, Tang WH, Starling RC, Moravec CS
Circulation. Heart failure 2014 Jul;7(4):612-8
Circulation. Heart failure 2014 Jul;7(4):612-8
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The S100A1 antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human S100A1. This antibody recognizes human, mouse, rat antigen. The S100A1 antibody has been validated for the following applications: ELISA, WB analysis.
